IP Library › Granted Patent US 9,102,713
Granted Patent B2
US 9,102,713 · App. 13/856,933 · Granted Aug 11, 2015

Analysis of ubiquitinated polypeptides

Inventors: John Edward Rush, II (Beverly, MA); Jing Li (Brighton, MA); Ailan Guo (Lexington, MA)
Assignee: Cell Signaling Technology, Inc.
C07K16/00G01N33/6842G01N2440/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,102,713
App. No.
13/856,933
Granted
Aug 11, 2015
Kind
B2
Abstract

The invention relates to antibody reagents that specifically bind to peptides carrying a ubiquitin remnant from a digested or chemically treated biological sample. The reagents allow the technician to identify ubiquitinated polypeptides as well as the sites of ubiquitination on them. The reagents are preferably employed in proteomic analysis using mass spectrometry. The antibody reagents specifically bind to the remnant of ubiquitin (i.e., a diglycine modified epsilon amine of lysine) left on a peptide which as been generated by digesting or chemically treating ubiquitinated proteins. The inventive antibody reagents' affinity to the ubiquitin remnant does not depend on the remaining amino acid sequences flanking the modified (i.e., ubiquitinated) lysine, i.e., they are context independent.

Claims (5)

1. An isolated antibody that preferentially binds a ubiquitin remnant peptide over a peptide having the same amino acid sequence as the ubiquitin remnant peptide but lacking a ubiquitin remnant, wherein the antibody comprises a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8.

2. The isolated antibody of claim 1 , wherein the antibody comprises a heavy chain sequence comprising SEQ ID NO: 1.

3. The isolated antibody of claim 1 , wherein the antibody comprises a light chain sequence comprising SEQ ID NO: 2.

4. An isolated antibody that preferentially binds a ubiquitin remnant peptide over a peptide having the same amino acid sequence as the ubiquitin remnant peptide but lacking a ubiquitin remnant, wherein the antibody comprises the variable region of the heavy chain set forth in SEQ ID NO: 1.

5. An isolated antibody that preferentially binds a ubiquitin remnant peptide over a peptide having the same amino acid sequence as the ubiquitin remnant peptide but lacking a ubiquitin remnant, wherein the antibody comprises the variable region of the light chain set forth in SEQ ID NO: 2.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2013
From: RUSH, JOHN EDWARD, II; LI, JING; GUO, AILAN
To: CELL SIGNALING TECHNOLOGY, INC.
Reel/Frame 030558/0427 →
Continuity (8)
Division 12967284 · Dec 14, 2010
Continuation In Part 11823775 · Jun 28, 2007
Division 10777893 · Feb 12, 2004
Continuation In Part 10175486 · Jun 19, 2002
Provisional Application 60299893 · Jun 21, 2001
Provisional Application 60337012 · Nov 8, 2001
Provisional Application 61286486 · Dec 15, 2009
Related Publication 20130245237A1 · Sep 19, 2013